Tag: PFE
-
Volatility-Proof Income: Dividend ETFs With Steady Payouts
Dividend ETFs can provide stability by delivering regular payouts and offering exposure to quality companies with proven track records.
-
Insider Buying: Why Executives Are Buying into These 3 Stocks
For investors, insider buying is one piece of the puzzle—alongside earnings, valuation, growth prospects and risks, not a standalone reason to buy a stock.
-
Pfizer’s Personalized Medicine Strategy Looks Ready to Pay Off
For investors looking to play the personalized medicine theme, Pfizer offers a diversified pipeline, an oncology franchise, and a dividend yield near 6%.
-
There’s Big Insider Buying at Pfizer, Berkshire, and Albertsons
Executives at Pfizer, Berkshire Hathaway and Albertsons are insider buying. Here’s what their purchases could signal.
-
Is Pfizer’s Pipeline Big Enough to Buy PFE for Its Dividend Today?
Pfizer (NYSE: PFE) finds itself at a crossroads that dividend investors know well. The stock has been beaten up, the yield looks attractive, and the company is telling a compelling growth story. But is it real? With 96 pipeline candidates, including 31 in Phase 3, a freshly beaten-down share price, and a Q1 2026 earnings…
-
Protect Your Portfolio with 3 High-Yielding Dividend ETFs
In uncertain markets, dividend ETFs —especially those emphasizing companies with long histories of growing payouts—can help anchor your portfolio.
-
Why ‘COVID Darling’ Novavax (NVAX) Stock Is on a Comeback Trail
After a sizable collapse following the global pandemic, NVAX stock may be one of the more intriguing high-risk wagers for market gamblers to consider.
-
3 Big Pharmaceutical Stocks for Every Investing Style
Pharmaceutical stocks – StockEarnings